NewsFeeder
01-26-2018, 03:30 PM
The Hot Stock & Biggest Loser: AbbVie & Wynn Resorts
AbbVie soared $14.91, or 13.8%, to $123.21. Cowen & Co.'s*Steve Scala*and his team reiterated an Outperform rating on AbbVie and raised their price target from $105 to $130, citing its increased visibility and earnings growth. Shares of AbbVie have gained nearly 27% year to date, and are up more than 100% in the past 12 months.
http://finance.yahoo.com/r/774eeb11-4110-3a3b-95e2-1db77451c6c2/the-hot-stock-biggest-loser-abbvie-wynn-resorts-1517002053?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss
AbbVie soared $14.91, or 13.8%, to $123.21. Cowen & Co.'s*Steve Scala*and his team reiterated an Outperform rating on AbbVie and raised their price target from $105 to $130, citing its increased visibility and earnings growth. Shares of AbbVie have gained nearly 27% year to date, and are up more than 100% in the past 12 months.
http://finance.yahoo.com/r/774eeb11-4110-3a3b-95e2-1db77451c6c2/the-hot-stock-biggest-loser-abbvie-wynn-resorts-1517002053?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss